DSLT for Reducing Medication in Glaucoma
Recruiting
Observational Study
Primary Open Angle Glaucoma
Ocular Hypertension
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- The Eye Institute of West Florida · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective, single arm, open label study conducted at a single site to evaluate the efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in reducing medication burden in patients with medically controlled ocular hypertension or primary open angle glaucoma.
The study will assess the primary endpoint of reduction in medication count at 6 months compared to baseline. Secondary endpoi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients scheduled to undergo DSLT treatment in one or both eyes.
* Diagnosis of ocular hypertension or primary open angle glaucoma (POAG).
* Medically controlled on 1-3 topical ocular hypotensive agents with IOP ≤21 mmHg.
Exclusion Criteria:
* Previous glaucoma sur…
Contacts